Differential Regulation of mTOR Complexes with miR-302a Attenuates Myocardial Reperfusion Injury in Diabetes
Summary: Persistent activation of mTOR (mammalian target of rapamycin) in diabetes increases the vulnerability of the heart to ischemia/reperfusion (I/R) injury. We show here that infusion of rapamycin (mTOR inhibitor) at reperfusion following ischemia reduced myocardial infarct size and apoptosis w...
Main Authors: | Arun Samidurai, Ramzi Ockaili, Chad Cain, Sean K. Roh, Scott M. Filippone, Donatas Kraskauskas, Rakesh C. Kukreja, Anindita Das |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004220310609 |
Similar Items
-
Preclinical model of type 1 diabetes and myocardial ischemia/reperfusion injury in conscious rabbits—demonstration of cardioprotection with rapamycin
by: Arun Samidurai, et al.
Published: (2021-09-01) -
Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases
by: Arun Samidurai, et al.
Published: (2018-01-01) -
Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK
by: Scott M. Filippone, et al.
Published: (2017-01-01) -
Inhibition of mTOR Signaling Protects Against Myocardial Reperfusion Injury, Acute Myocardial Infarction
by: Filippone, Scott M
Published: (2015) -
Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
by: Sofie Mohlin, et al.
Published: (2019-08-01)